,,ii  #aahth ,,congress  #ast ,session  
,s4 #bjhe  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #ba1     
#bjbc,mr4 ,crapo 7for himself1 ,mr4     
,bennet1 ,mr4 ,scott of ,south          
,carolina1 and ,mr4 ,cardin7 introduced 
the following bill2 which was read twice
 and referred to the ,committee on      
,finance  ,a ,,bill  ,to amend title    
,,xviii of the ,social ,security ,act to
 provide for ,medicare coverage of      
multi-cancer early detection screening  
tests4  #a4 ,short title ,this ,act may 
be cited as the ,medicare ,multi-,cancer
 ,early ,detection ,screening ,coverage 
,act 4  #b4 ,purpose ,the purpose of    
this ,act is to create a covered benefit
 for multi-cancer early detection       
screening tests to ensure ,medicare     
beneficiary access to these tests       
without unnecessary delay once approved 
under the ,federal ,food1 ,drug1 and    
,cosmetic ,act4  #c4 ,medicare coverage 
of multi-cancer early detection         
screening tests  7a7 ,coverage ,section 

#ahfa of the ,social ,security ,act 7#db
 ,u4,s4,c4 #aciex7 is amended-- 7#a7 in 
subsection 7s77#b7-- 7,a7 by striking   
the semicolon at the end of subparagraph
 7,,jj7 and inserting 2 and2 and  7,b7  
by adding at the end the following new  
subparagraph3  7,,kk7 multi-cancer early
 detection screening tests 7as defined  
in subsection 7nnn772  2 and  7#b7 by   
adding at the end the following new     
subsection3  7nnn7 ,multi-,cancer early 
detection screening tests ,the term     
multi-cancer early detection screening  
test means any of the following tests1  
approved or cleared by the ,food and    
,drug ,administration1 insofar as the   
,secretary determines coverage of such  
tests is appropriate1 furnished to an   
individual for the purpose of earlier   
detection of cancer across many cancer  
types 7such as described in the         
,national ,cancer ,institute's ,annual  
,report to the ,nation on the ,status of
 ,cancer73 7#a7 ,a genomic sequencing   
blood or blood product test that        

includes the analysis of cell-free      
nucleic acids4  7#b7 ,such other        
equivalent tests 7which are based on    
blood1 blood products1 urine1 or other  
sample of biological material7 as the   
,secretary determines appropriate in    
providing results comparable to those   
obtained with a test described in       
paragraph 7#a74  4  7b7 ,payment and    
frequency limit  7#a7 ,payment under fee
 schedule ,section #ahcc7;h7 of the     
,social ,security ,act 7#db ,u4,s4,c4   
#aciel7h77 is amended-- 7,a7 in         
paragraph 7#a77;,a71 by inserting after 
7including the following3 multi-cancer  
early detection screening tests under   
section #ahfa7nnn71 and including2 and  
7,b7 by adding at the end the following 
new paragraph3  7#aj7 ,no payment may be
 made under this part for a multi-cancer
 early detection screening test 7as     
defined in section #ahfa7nnn77 for an   
individual if such a test was furnished 
to the individual during the previous   
#aa months4  4  7#b7 ,conforming        

amendment ,section #ahfb7;a7 of the     
,social ,security ,act 7#db ,u4,s4,c4   
#aciey7a77 is amended-- 7,a7 in         
paragraph 7#a7-- 7i7 in subparagraph    
7,o71 by striking and at the end2  7ii7 
in subparagraph 7,p71 by striking the   
semicolon at the end and inserting 1    
and2 and  7iii7 by adding at the end the
 following new subparagraph3  7,q7 in   
the case of a multi-cancer early        
detection screening test 7as defined in 
section #ahfa7nnn771 which is performed 
more frequently than is covered under   
section #ahcc7;h77#aj72  2 and  7,b7 in 
paragraph 7#g71 by striking or 7,p7 and 
inserting 7,p71 or 7,q74  7c7 ,rule of  
construction relating to other cancer   
screening tests ,nothing in this        
section1 including the amendments made  
by this section1 shall be construed--   
7#a7 in the case of an individual who   
undergoes a multi-cancer early detection
 screening test1 to affect coverage     
under part ,b of title ,,xviii of the   
,social ,security ,act for other cancer 

screening tests covered under such      
title1 such as screening tests for      
breast1 cervical1 colorectal1 lung1 or  
prostate cancer2 or  7#b7 in the case of
 an individual who undergoes another    
cancer screening test1 to affect        
coverage under such part for a          
multi-cancer early detection screening  
test or the use of such a test as a     
diagnostic or confirmatory test for a   
result of the other cancer screening    
test4